Doximity Given New 48.00 Price Target at JPMorgan Chase Co.
| DOCS Stock | USD 71.71 0.80 1.10% |
Slightly above 62% of Doximity's investor base is looking to short. The analysis of the overall investor sentiment regarding Doximity suggests that many traders are alarmed. Doximity's investing sentiment can be driven by a variety of factors including economic data, Doximity's earnings reports, geopolitical events, and overall market trends.
Doximity |
Doximity had its price target increased by JPMorgan Chase Co. from 30.00 to 48.00 in a research report report published on Thursday,Benzinga reports. JPMorgan Chase Co. currently has a neutral rating on the stock. Other equities analysts have also issued reports about the stock. Morgan Stanley raised shares of
Read at thelincolnianonline.com
 |
Doximity Fundamental Analysis
We analyze Doximity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Doximity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Doximity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Doximity is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Doximity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Doximity stock to make a market-neutral strategy. Peer analysis of Doximity could also be used in its relative valuation, which is a method of valuing Doximity by comparing valuation metrics with similar companies.
Peers
Doximity Related Equities
| TXG | 10X Genomics | 4.86 | ||||
| SDGR | Schrodinger | 3.09 | ||||
| VEEV | Veeva Systems | 2.65 | ||||
| DH | Definitive Healthcare | 2.62 | ||||
| ACCD | Accolade | 0.14 | ||||
| PGNY | Progyny | 0.09 | ||||
| GEHC | GE HealthCare | 0.11 | ||||
| CERT | Certara | 0.40 | ||||
| TDOC | Teladoc | 1.70 | ||||
| HQY | HealthEquity | 1.71 | ||||
| AMWL | American Well | 2.41 |
Additional Tools for Doximity Stock Analysis
When running Doximity's price analysis, check to measure Doximity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Doximity is operating at the current time. Most of Doximity's value examination focuses on studying past and present price action to predict the probability of Doximity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Doximity's price. Additionally, you may evaluate how the addition of Doximity to your portfolios can decrease your overall portfolio volatility.